Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
5 On Your Side shares 7 simple ways to cut down your energy bill this summer
Recommended
Q&A: Preparing dogs for summertime heat
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
40.31
-0.24 (-0.59%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,780,298
Open
40.47
Bid (Size)
40.00 (10)
Ask (Size)
40.45 (10)
Prev. Close
40.55
Today's Range
40.19 - 40.48
52wk Range
33.67 - 45.92
Shares Outstanding
5,385,189,617
Dividend Yield
3.58%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract
June 24, 2024
Pfizer secures a UK contract to supply millions of doses of its Abrysvo RSV vaccine, surpassing GSK's bid. The agreement includes doses for older adults and pregnant mothers.
Via
Benzinga
Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
June 20, 2024
GSK, supported by major industry groups, seeks to stop 70,000 Zantac lawsuits in Delaware, arguing a recent court ruling threatens the state's business-friendly reputation and judicial consistency.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Performance
YTD
+7.46%
+7.46%
1 Month
-8.88%
-8.88%
3 Month
-5.88%
-5.88%
6 Month
+8.92%
+8.92%
1 Year
+11.14%
+11.14%
More News
Read More
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
June 18, 2024
Via
Benzinga
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
Via
InvestorPlace
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Via
InvestorPlace
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
June 10, 2024
Via
Investor's Business Daily
Exposures
COVID-19
US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk
June 07, 2024
From
GSK plc
Via
Business Wire
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
June 06, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Large Cap BIopharmaceuticals Overview
June 03, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
June 03, 2024
Via
InvestorPlace
Topics
Lawsuit
Exposures
Financial
Legal
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma
June 03, 2024
Via
Benzinga
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward
June 03, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 03, 2024
Via
Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 03, 2024
Via
Benzinga
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
June 03, 2024
From
GSK plc
Via
Business Wire
Is Moderna Stock a Buy Now That It's a 2-Product Company?
June 03, 2024
Via
The Motley Fool
Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
June 03, 2024
Via
Benzinga
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
June 02, 2024
From
GSK plc
Via
Business Wire
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
May 31, 2024
Via
Investor's Business Daily
Exposures
Product Safety
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
May 27, 2024
Via
Benzinga
Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit
May 24, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
May 22, 2024
Via
Benzinga
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
May 21, 2024
Via
Benzinga
Topics
Lawsuit
Whistleblower
Exposures
Financial
Legal
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.